Nancy Hutson
Président chez BIOCRYST PHARMACEUTICALS, INC.
Fortune : 478 409 $ au 30/04/2024
Profil
Nancy J.
Hutson is currently the Chairman at BioCryst Pharmaceuticals, Inc. and the Vice Chairman-Trustees Board at Illinois Wesleyan University.
She is also an Independent Director at PhaseBio Pharmaceuticals, Inc., Endo International Plc, Clearside Biomedical, Inc., and Lipidio Pharmaceuticals, Inc. Additionally, she serves as a Director at Thirona Bio, Inc., a Scientific Advisor at Hatteras Venture Partners, and is the Owner of Ledyard Co. In her former positions, Dr. Hutson served as an Independent Director at Cubist Pharmaceuticals LLC from 2011 to 2015, and at Endo Health Solutions, Inc. from 2011 to 2014.
She was also a Director at Inspire Pharmaceuticals, Inc. from 2006 to 2011.
Furthermore, she held positions as a Director at Endo Pharmaceuticals, Inc., the University of Connecticut Health Center, Connecticut Business & Industry Association, African Medical & Research Foundation, and Planned Parenthood of Connecticut, Inc. Prior to these roles, she worked at Pfizer Inc. from 1981 to 2006, where she held the position of Senior VP-Global Research & Development.
Dr. Hutson obtained a doctorate degree from Vanderbilt University and an undergraduate degree from Illinois Wesleyan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2024 | 86 818 ( 0,04% ) | 361 163 $ | 30/04/2024 | |
| 15/04/2024 | 93 000 ( 0,12% ) | 117 180 $ | 30/04/2024 | |
ENDO INTERNATIONAL PLC
0,05% | 12/04/2023 | 109 625 ( 0,05% ) | 66 $ | 30/04/2024 |
| 19/05/2023 | 41 510 ( 0,08% ) | - $ | 31/01/2024 |
Postes actifs de Nancy Hutson
| Sociétés | Poste | Début |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Président | 31/03/2023 |
| ENDO INTERNATIONAL PLC | Directeur/Membre du Conseil | 28/02/2014 |
| PHASEBIO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/03/2018 |
| CLEARSIDE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 21/04/2020 |
Ledyard Co.
 Ledyard Co. Food DistributorsDistribution Services Part of Performance Food Group Co., Ledyard Co. is a distributor of food and equipment supplies to restaurants. The company is based in Santa Cruz, CA. Ledyard was acquired by PFG Holdings LLC on December 10, 2010. | Corporate Officer/Principal | 15/07/2009 |
Thirona Bio, Inc.
 Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Directeur/Membre du Conseil | - |
| Illinois Wesleyan University | Directeur/Membre du Conseil | - |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Directeur/Membre du Conseil | - |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Consultant / Advisor | - |
Anciens postes connus de Nancy Hutson
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Nancy Hutson
| Vanderbilt University | Doctorate Degree |
| Illinois Wesleyan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Connecticut Business & Industry Association is a non-profit organization that provides commercial support services. The private company is based in Hartford, CT. Joseph F. Brennan has been the CEO of the company since 1988. | Commercial Services |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
| African Medical & Research Foundation | |
Planned Parenthood of Connecticut, Inc.
 Planned Parenthood of Connecticut, Inc. Miscellaneous Commercial ServicesCommercial Services Planned Parenthood of Connecticut, Inc. operated organization for protect fundamental right of all individuals to manage their own fertility and sexual health. The company is headquartered in New Haven, CT. | Commercial Services |
Ledyard Co.
Ledyard Co. Food DistributorsDistribution Services Part of Performance Food Group Co., Ledyard Co. is a distributor of food and equipment supplies to restaurants. The company is based in Santa Cruz, CA. Ledyard was acquired by PFG Holdings LLC on December 10, 2010. | Distribution Services |
Lipidio Pharmaceuticals, Inc.
Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Health Technology |
Thirona Bio, Inc.
Thirona Bio, Inc. Pharmaceuticals: MajorHealth Technology Thirona Bio, Inc. is an American biopharmaceutical company that focuses on developing drugs for fibrotic diseases. Thirona Bio is based in an undisclosed location. The private company's target indications include scleroderma, keloid scars, and certain cancers where there are no effective therapies. The company's unique approach uses a potent, topically applied drug to inhibit TGF-? "locally," minimizing the potential risk of systemic toxicity. The company was founded by John Gordon Foulkes, Jay Edward Birnbaum, K. George Mooney, and David A. Bullough, with John Gordon Foulkes serving as the CEO since incorporation. | Health Technology |